Granuflo Lawsuit Injuries

Nicholas Gordon

Description

Due t o this leak, the FDA began to investigate the safety of GranuFlo and Granuflo Lawsuit Acid C http://granuflo - lawsuit - lawyer.com/ problems were first realized by Fresenius Me dical Care in 2011, but did not make it into the public eye until the FDA released this recall.

Informations

• Publié par: Traves376
• Publié le: 08 juin 2013
• Nombre de lectures: 50
• Licence : Tous droits réservés
• Langue: English

Extrait

Granuflo Lawsuit Injuries Fresenius Medical Care did not release this important information to the public. It is reported that the internal memo which Fresenius Medical Care only sent to its own clinics was leaked to the Food and Drug Administration. Due to this leak, the FDA began to investigate the safety ofGranuFlo and NaturaLyte. The FDA’s investigations lead them to issue a recall on March 29, 2012. This recall pertained directly to “Fresenius Medical Care North America, NaturaLyte andGranuflo Lawsuit Acid Concentrate.”

http://granuflolawsuitlawyer.com/ In the text of the recall, the FDA warns that “Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis.” These prescription/dosing problems were first realized by Fresenius Medical Care in 2011, but did not make it into the public eye until the FDA released this recall. This dosing information was very important because a high bicarbonate level in dialysis patients may contribute to a condition called Metabolic Acidosis. Metabolic Acidosis is associated with an increased risk of cardiopulmonary arrest, cardiac arrhythmia, Hypoxemia (low blood oxygen),Hypercapnia (increased carbon dioxide in the blood), andHypokalemia(low potassium levels in the blood. These are very dangerous conditions which need to be identified and treated or they can lead to even more serious medical consequences. Fresenius Medical Care attempted to correct this problem internally by changing the dosing procedures and guidelines, but they failed to inform the FDA in a

timely manner. While the FDA was finally made aware of the problems and released the updated guidelines publicly, the information came too late for many of the patients who had already experienced some very severe side effects such as heart attack, stroke, cardiac arrest, and even death.